Back |
home / stock / rapt / rapt message board
Subject | By | Source | When |
---|---|---|---|
Gleason is basically a scumbag. He and his | poincianamike | investorshub | 09/22/2012 7:12:20 PM |
How's this worthless stock doing today? Hmmm | Peggy | investorshub | 09/20/2012 1:25:31 PM |
Gleason may be in Malaysia ... who knows | Peggy | investorshub | 08/16/2012 4:01:27 PM |
Heard Gleason is in Maylasia looking for business. | poincianamike | investorshub | 08/10/2012 12:27:18 AM |
Done bailed from this stock, I play pumps | stockrookiehere | investorshub | 08/05/2012 10:37:56 PM |
Heard that Gleason the mad scientist is in | poincianamike | investorshub | 08/05/2012 8:30:24 PM |
Anbody in this besides me i've been sitting | stockrookiehere | investorshub | 06/26/2012 3:03:33 AM |
Yep ... a real strong day for $RAPT. | Peggy | investorshub | 05/29/2012 7:40:17 PM |
This is insane. I wouldn't be surprised if | AliEn BRaInZ stox | investorshub | 05/29/2012 6:42:55 PM |
Yes I see it but also E added | nofear | investorshub | 04/19/2012 1:19:31 PM |
News, Short Squeeze, Breakout and More Instantly...
RAPT Therapeutics Inc. Company Name:
RAPT Stock Symbol:
NYSE Market:
RAPT Therapeutics Inc. Website:
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamm...
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamm...
2024-02-23 01:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...